62018-55-7

Basic information

• Product Name: Benzaldehyde, 3-acetyl-2,4,6-trihydroxy-
• Synonyms: 3-Acetyl-2,4,6-trihydroxy-benzaldehyd;3'-formyl-2',4',6'-trihydroxyacetophenone;Benzaldehyde,3-acetyl-2,4,6-trihydroxy;formyl acetyl phloroglucinol;3-acetyl-2,4,6-trihydroxy-benzaldehyde
• CAS NO: 62018-55-7
• Molecular Formula: C9H8O5
• Molecular Weight: 196.16
• Mol File: 62018-55-7.mol
• Article Data: 6

Chemical Properties

• Melting Point: 180–182°C
• CAS DataBase Reference: Benzaldehyde, 3-acetyl-2,4,6-trihydroxy-(CAS DataBase Reference)
• NIST Chemistry Reference: Benzaldehyde, 3-acetyl-2,4,6-trihydroxy-(62018-55-7)
• EPA Substance Registry System: Benzaldehyde, 3-acetyl-2,4,6-trihydroxy-(62018-55-7)

Safety Data

• Hazardous Substances Data: 62018-55-7(Hazardous Substances Data)

Usage

Preparation

Obtained by reaction of acetonitrile with 2,4,6-trihydroxy-benzaldehyde (Houben-Hoesch reaction) Also obtained by reaction of ethyl orthoformate with phloracetophenone in the presence of aluminium chloride Preparation by adding successively zinc cyanide and aluminium chloride to a solution of phloracetophenone in ethyl ether. The reaction mixture was cooled in ice and saturated with hydrogen chlorideAlso obtained by reaction of DMF with phloracetophenone in the presence of phosphorous oxychloride at 20° for 1 h (70%).

Upstream product

• 108-73-6 3,5-dihydroxyphenol 
• 480-66-0 2,4,6-trihydroxyacetophenone 
• 68-12-2 N,N-dimethyl-formamide 
• 7647-01-0 hydrogenchloride 
• 7446-70-0 aluminium trichloride 
• 122-51-0 orthoformic acid triethyl ester 

Downstream Products

• 59677-81-5 3-acetyl-2,4,6-trihydroxy-5-methylbenzaldehyde 
• 140170-49-6 methyl 3-<3,4-dihydroxy-5-(4-hydroxycinnamoyl)-2-methoxy-3-methyl-6-oxo-1,4-cyclohexadienyl>-3-(4-hydroxyphenyl)propanoate 
• 140170-50-9 methyl 3-<2,3,4-trihydroxy-5-(4-hydroxycinnamoyl)-3-methyl-6-oxo-1,4-cyclohexadienyl>-3-(4-hydroxyphenyl)propanoate 
• 140170-51-0 3-<2,3,4-trihydroxy-5-(4-hydroxycinnamoyl)-3-methyl-6-oxo-1,4-cyclohexadienyl>-3-(4-hydroxyphenyl)propanoic acid 
• 140170-48-5 methyl 3-(5-acetyl-3,4-dihydroxy-2-methoxy-3-methyl-6-oxo-1,4-cyclohexadienyl)-3-(4-hydroxyphenyl)propanoate 
• 140170-47-4 methyl 3-(5-acetyl-2,3,4-trihydroxy-3-methyl-6-oxo-1,4-cyclohexadienyl)-3-(4-hydroxyphenyl)propanoate 
• 140170-45-2 6-acetyl-3,4-dihydro-5,7-dihydroxy-8-methyl-4-(4-hydroxyphenyl)coumarin 
• 140170-46-3 8-acetyl-3,4-dihydro-5,7-dihydroxy-6-methyl-4-(4-hydroxyphenyl)coumarin 
• 2657-28-5 2,4,6-trihydroxy-3-methyl-acetophenon 

Relevant articles and documents

The Mosaic of Rottlerin

The first total synthesis of rottlerin is described. The methodology allows the development of potential novel protein kinase C δ (PKCδ) analogues for better treatment of various diseases. Kamalachalcone A and dimeric rottlerin were synthesized in a very

Biomimetic synthesis, antimicrobial, antileishmanial and antimalarial activities of euglobals and their analogues

In the present communication, naturally occurring phloroglucinol- monoterpene adducts, euglobals G1-G4 (3b/a and 4a/b) and 16 new analogues (13a/b-18a/b and 19-22) were synthesized by biomimetic approach. These synthetic compounds differ from natural euglobals in the nature of monoterpene and acyl functionality. All of these compounds were evaluated for their antibacterial, antifungal, antileishmanial and antimalarial activities. Analogue 17b possessed good antibacterial activity against methicillin-resistant Staphylococcus aureus, while analogues 19-22 possessed potent antifungal activity against Candida glabrata with IC50s ranging from 1.5 to 2.5 μg/mL. Euglobals along with all synthesized analogues exhibited antileishmanial activity. Amongst these, euglobal G2 (3a), G3 (4a) and analogues 13a and 14a showed potent antileishmanial activity with IC50s ranging from 2.8 to 3.9 μg/mL. Analogue 16a possessed antimalarial activity against chloroquine sensitive D6 clone of Plasmodium falciparum. None of the compounds showed toxicity against mammalian kidney fibroblasts (vero cells) upto the concentration of 4.76 μg/ml.

Macrocarpals, Antibacterial Compounds from Eucalyptus, Inhibit Aldose Reductase

-